Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27775120 | 1.00 | DGAT1 (0.43) | DGAT1CA12CA1CA7CA14 | |
| SCHEMBL27795979 | 1.00 | DGAT1 (0.43) | DGAT1CA12CA1CA7CA14 | |
| SCHEMBL25388987 | 0.84 | DGAT1 (0.41) | DGAT1CA1TDP1 | |
| SCHEMBL30690429 | 0.82 | DGAT1 (0.40) | DGAT1 | |
| SCHEMBL6535584 | 0.81 | FDPS (0.38) | DGAT1CA12CA1CA7CA14 | |
| SCHEMBL14485423 | 0.81 | DGAT1 (0.48) | DGAT1CA12CA1CA7CA14 | |
| SCHEMBL1433036 | 0.81 | DGAT1 (0.43) | DGAT1CA12CA1CA7CA14 | |
| SCHEMBL14485421 | 0.81 | DGAT1 (0.48) | DGAT1CA12CA1CA7CA14 | |
| SCHEMBL12860069 | 0.81 | DGAT1 (0.48) | DGAT1CA12CA1CA7CA14 | |
| SCHEMBL8489844 | 0.81 | DGAT1 (0.43) | DGAT1CA12CA1CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115449065-B | NAC modified blood purification membrane and preparation method thereof | 中南大学湘雅医院 | 2023-09-22 | — | — | CN | claimed |
| CN-115449065-A | NAC (N-acetyl-D) -modified blood purification membrane and preparation method thereof | 中南大学湘雅医院 | 2022-12-09 | — | — | CN | claimed |
| CN-105542154-A | Polylactic acid preparation method | SHAANXI YUHANG ELECTRONICS CO LTD | 2016-05-04 | — | — | CN | claimed |
| EP-1511471-B9 | COLLOIDAL SUSPENSION OF SUBMICRONIC PARTICLES FOR DELIVERING ACTIVE PRINCIPLES AND METHOD FOR PREPARING SAME | FLAMEL TECH SA (FR) | 2011-04-20 | — | — | EP | claimed |
| EP-1511471-B1 | COLLOIDAL SUSPENSION OF SUBMICRONIC PARTICLES FOR DELIVERING ACTIVE PRINCIPLES AND METHOD FOR PREPARING SAME | FLAMEL TECH SA (FR) | 2011-02-02 | — | — | EP | claimed |
| JP-2005529888-A | — | — | 2005-10-06 | — | — | JP | claimed |
| EP-1511471-A1 | COLLOIDAL SUSPENSION OF SUBMICRONIC PARTICLES FOR DELIVERING ACTIVE PRINCIPLES AND METHOD FOR PREPARING SAME | Flamel Technologies (FR) | 2005-03-09 | — | — | EP | claimed |
| WO-2003090727-A1 | COLLOIDAL SUSPENSION OF SUBMICRONIC PARTICLES FOR DELIVERING ACTIVE PRINCIPLES AND METHOD FOR PREPARING SAME | FLAMEL TECHNOLOGIES (FR) | 2003-11-06 | — | — | WO | claimed |
| CN-115449065-B | NAC modified blood purification membrane and preparation method thereof | 中南大学湘雅医院 | 2023-09-22 | — | — | CN | disclosed |
| CN-115449065-A | NAC (N-acetyl-D) -modified blood purification membrane and preparation method thereof | 中南大学湘雅医院 | 2022-12-09 | — | — | CN | disclosed |
| EP-3366680-B1 | DENDRIMER LIKE AMINO AMIDES POSSESSING SODIUM CHANNEL BLOCKER ACTIVITY FOR THE TREATMENT OF DRY EYE AND OTHER MUCOSAL DISEASES | PARION SCIENCES INC (US) | 2020-05-13 | — | — | EP | disclosed |
| EP-2497785-B1 | Hyaluronic acid derivative and drug containing the same | SEIKAGAKU KOGYO CO LTD (JP) | 2018-09-12 | — | — | EP | disclosed |
| EP-3366680-A1 | DENDRIMER LIKE AMINO AMIDES POSSESSING SODIUM CHANNEL BLOCKER ACTIVITY FOR THE TREATMENT OF DRY EYE AND OTHER MUCOSAL DISEASES | Parion Sciences, Inc. (US) | 2018-08-29 | — | — | EP | disclosed |
| EP-3363463-A2 | HYALURONIC ACID DERIVATIVE AND DRUG CONTAINING THE SAME | Seikagaku Corporation (JP) | 2018-08-22 | — | — | EP | disclosed |
| EP-0999220-A2 | Low molecular weight peptidomimetic growth hormone secretagogues | Genentech, Inc. (US) | 2000-05-10 | — | — | EP | disclosed |
| WO-2000012509-A2 | COLLECTIONS OF COMPOUNDS | SPIROGEN LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |
| WO-2000012508-A2 | PYRROLBENZODIAZEPINES | SPIROGEN LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |
| US-6034216-A | Low molecular weight peptidomimetic growth hormone secretagogues | GENENTECH INC. (US) | 2000-03-07 | — | — | US | disclosed |
| US-5798337-A | USED TO PROMOTE GROWTH IN MAMMALS EITHER ALONE OR IN COMBINATION WITH OTHER GROWTH PROMOTING COMPOUNDS | GENENTECH, INC. (US) | 1998-08-25 | — | — | US | disclosed |
| WO-1997021666-A1 | ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS | GLAXO GROUP LIMITED (GB) | 1997-06-19 | — | — | WO | disclosed |